Aim: The “2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid
Hemorrhage” replaces the 2012 “Guidelines for the Management of Aneurysmal …

Aneurysmal subarachnoid hemorrhage (aSAH) continues to be associated with significant
morbidity and mortality despite advances in care and aneurysm treatment strategies …

Purpose—The aim of this guideline is to present current and comprehensive
recommendations for the diagnosis and treatment of aneurysmal subarachnoid hemorrhage …

A large series of different ion channels have been identified and investigated as potential
targets for new medicines for the treatment of a variety of human diseases, including pain …

Despite advancements in treating ruptured cerebral aneurysms, an aneurysmal
subarachnoid hemorrhage (aSAH) is still a grave cerebrovascular disease associated with a …

Objectives To examine the clinical outcome of aneurysmal subarachnoid haemorrhage
(aSAH) patients exposed to cerebral vasospasm (CVS)-targeted treatments in a meta …

Large vessel ischemic stroke represents the most disabling subtype. While t-PA and
endovascular thrombectomy can recanalize the occluded vessel, good clinical outcomes are …

Background Vasospasm is a treatable cause of deterioration following aneurysmal
subarachnoid hemorrhage. Cerebral computed tomography perfusion mean transit times …

This article highlights the pathogenesis and management of cerebral vasospasm. It
discusses the various pharmacological, endovascular, and neurosurgical approaches …

Vasospasm, initial neurological damage, rebleeding, and periprocedural complications are
associated prognostic factors for clinical outcomes after aneurysmal subarachnoid …